Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.
Phase of Trial: Phase I
Latest Information Update: 26 Jan 2016
At a glance
- Drugs Carboplatin; Paclitaxel; Temozolomide
- Indications Small cell lung cancer
- Focus Adverse reactions
- 19 Jan 2016 Trial focus changed from Therapeutic use and Adverse events to only Adverse events:- Overall tumor response rate removed from primary endpoint as per ClinicalTrials.gov. record.
- 19 Sep 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.